Abstract
CyberKnife has been proposed as a new treatment technology for accelerated partial breast irradiation (APBI). Detailed dosimetric studies for CyberKnife-based APBI are critically needed before it can be offered routinely to patients. In this dosimetric study, CyberKnife treatment planning was performed and dose calculations by Monte Carlo (MC) and ray-tracing (R-T) method were compared.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
